(Q43430750)

English

Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors

scientific article published in July 2007

In more languages
default for all languages
No label defined

No description defined

Statements

Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors (English)
0 references
Patrizia Siegert
Michael Medinger
Juliane M Jürgensmeier
Thomas A Puchalski

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit